Loss-of-function mutations of PTCH1/2 result in aberrant activation of Hedgehog signal pathway, and are driver oncogenic mutations in some tumor types, including basal cell carcinoma, medulloblastoma and rhabdomyosarcoma [30–34]. This evidence concerns the gene PTCH1 and rhabdomyosarcoma.